Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals. (1st April 2017) - Mose, K.F.; Andersen, F.; Skov, L.; Røpke, M.A.; Litman, T.; Friedmann, P.S.; Andersen, K.E.